Clinical Characteristics of Coronavirus Disease 2019 in a Cohort of Iranian Patients: Olfactory Dysfunction as a Frequent Clinical Presentation
Keywords:COVID-19, Iran, SARS-CoV-2, Olfactory dysfunction;
Background: Since its outbreak, the 2019 novel coronavirus (SARS-CoV-2) has been associated with
coronavirus disease 2019 (COVID-19). The full spectrum of disease severity of COVID-19 is still unknown.
In this study which is the first report from Iran, we showed that olfactory dysfunction is a frequent clinical
manifestation among COVID-19 patients.
Methods: All patients with suspected SARS-CoV-2 infection were admitted to Arak hospitals in Iran. We
retrospectively collected and analyzed data on patients with either laboratory-confirmed SARS-CoV-2
infection by real-time RT-PCR and/or chest CT
Results: Most patients in our cohort had mild COVID-19 (104 [60.4%] of 172) . Common symptoms at
the onset of disease included (subjective) fever (131 [76%] of 172 patients), cough (130 [75.5%]), myalgia
(107 [62%]) dyspnea (92 [53.5%]), chills (96 [55.8%]), and headache (94 [54.6%]). Olfactory dysfunction
(OD), including anosmia, hyposmia, hyperosmia, and dysosmia, were reported by 61 ([36.5%] of 167)
patients. The most common concurrent symptoms beside the olfactory dysfunctions, were fever (39 [69.6%]
of 56 patients) and chills (26 [46.4%]), respectively. For the most part, the patient’s condition worsened
after the notice of anosmia/dysgeusia (48 [85.7%] of 56 patients). The majority of anosmic patients were
recovered from COVID-19 (50 [89.3%] of 56 patients). The anosmia/dysgeusia was resolved in 42 [75%]
of 56 patients after two weeks.
Conclusion: Taken together, this study reports the disease spectrum of SARS-CoV-2 infection in a cohort of
172 Iranian adult patients. To the best of our knowledge, this is the first report from Iran.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions